{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:24:11Z","timestamp":1792621451944,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,4,12]],"date-time":"2018-04-12T00:00:00Z","timestamp":1523491200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s11606-018-4436-4","type":"journal-article","created":{"date-parts":[[2018,4,12]],"date-time":"2018-04-12T14:29:41Z","timestamp":1523543381000},"page":"1100-1108","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Performance of the 2015 US Preventive Services Task Force Screening Criteria for Prediabetes and Undiagnosed Diabetes"],"prefix":"10.1007","volume":"33","author":[{"given":"Matthew J.","family":"O\u2019Brien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai McKeever","family":"Bullard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward W.","family":"Gregg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes R.","family":"Carnethon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namratha R.","family":"Kandula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald T.","family":"Ackermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,12]]},"reference":[{"issue":"10","key":"4436_CR1","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1001\/jama.2015.10029","volume":"314","author":"A Menke","year":"2015","unstructured":"Menke A, Casagrande S, Geiss L, Cowie CC. Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012. JAMA. 2015 Sep 8;314(10):1021\u20139.","journal-title":"JAMA."},{"issue":"9","key":"4436_CR2","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.2337\/diacare.28.9.2280","volume":"28","author":"LC Lanting","year":"2005","unstructured":"Lanting LC, Joung IM, Mackenbach JP, Lamberts SW, Bootsma AH. Ethnic differences in mortality, end-stage complications, and quality of care among diabetic patients: a review. Diabetes Care. 2005 Sep;28(9):2280\u20138.","journal-title":"Diabetes Care."},{"issue":"11","key":"4436_CR3","doi-asserted-by":"publisher","first-page":"861","DOI":"10.7326\/M15-2345","volume":"163","author":"AL Siu","year":"2015","unstructured":"Siu AL. Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2015 Dec 1;163(11):861\u20138.","journal-title":"Ann Intern Med."},{"issue":"4","key":"4436_CR4","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1001\/jama.2015.18448","volume":"315","author":"H Bauchner","year":"2016","unstructured":"Bauchner H, Fontanarosa PB, Golub RM. JAMA Welcomes the US Preventive Services Task Force. JAMA. 2016 Jan 26;315(4):351\u20132.","journal-title":"JAMA."},{"key":"4436_CR5","volume-title":"Screening for Abnormal Glucose and Type 2 Diabetes Mellitus: A Systematic Review to Update the 2008 U.S. Preventive Services Task Force Recommendation","author":"S Selph","year":"2015","unstructured":"Selph S, Dana T, Bougatsos C, Blazina I, Patel H, Chou R. Screening for Abnormal Glucose and Type 2 Diabetes Mellitus: A Systematic Review to Update the 2008 U.S. Preventive Services Task Force Recommendation. Rockville, MD: Agency for Healthcare Research and Quality; 2015."},{"issue":"Suppl 1","key":"4436_CR6","first-page":"S1","volume":"40","author":"American Diabetes Association","year":"2017","unstructured":"American Diabetes Association. Standards of Medical Care in Diabetes-2017. Diabetes Care. 2017 Jan;40(Suppl 1):S1-S135.","journal-title":"Diabetes Care."},{"issue":"6","key":"4436_CR7","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJMoa012512","volume":"346","author":"W Knowler","year":"2002","unstructured":"Knowler W, Barrett-Connor E, Fowler S, Hamman RF, Lachin J, Walker E, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393\u2013403.","journal-title":"N Engl J Med."},{"issue":"4","key":"4436_CR8","doi-asserted-by":"publisher","first-page":"537","DOI":"10.2337\/diacare.20.4.537","volume":"20","author":"XR Pan","year":"1997","unstructured":"Pan XR, Li G, Hu YH, Wang JX, Yang WY, An ZX, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20(4):537\u201344.","journal-title":"Diabetes Care."},{"issue":"18","key":"4436_CR9","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","volume":"344","author":"J Tuomilehto","year":"2001","unstructured":"Tuomilehto J, Lindstr\u00f6m J, Eriksson JG, Valle TT, H\u00e4m\u00e4l\u00e4inen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344(18):1343\u201350.","journal-title":"N Engl J Med."},{"key":"4436_CR10","unstructured":"Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, 2011."},{"issue":"17","key":"4436_CR11","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1001\/jama.2014.3201","volume":"311","author":"D Dabelea","year":"2014","unstructured":"Dabelea D, Mayer-Davis EJ, Saydah S, Imperatore G, Linder B, Divers J, et al. Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. JAMA. 2014 May 7;311(17):1778\u201386.","journal-title":"JAMA."},{"key":"#cr-split#-4436_CR12.1","unstructured":"2. Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey. Atlanta, GA: CDC\/National Center for Health Statistics, 2016"},{"key":"#cr-split#-4436_CR12.2","unstructured":"3. Available from:   http:\/\/www.cdc.gov\/nchs\/nhanes.htm    [accessed February 27, 2018]."},{"key":"4436_CR13","first-page":"1","volume":"162","author":"CL Johnson","year":"2014","unstructured":"Johnson CL, Dohrmann SM, Burt VL, Mohadjer LK. National health and nutrition examination survey: sample design, 2011-2014. Vital Health Statistics. 2014 Mar(162):1\u201333.","journal-title":"Vital Health Statistics."},{"issue":"14","key":"4436_CR14","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1001\/jama.290.14.1884","volume":"290","author":"KMV Narayan","year":"2003","unstructured":"Narayan KMV, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF. Lifetime risk for diabetes mellitus in the United States. JAMA. 2003;290(14):1884\u201390.","journal-title":"JAMA."},{"issue":"5","key":"4436_CR15","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1093\/ajcn\/87.5.1212","volume":"87","author":"GA Bray","year":"2008","unstructured":"Bray GA, Jablonski KA, Fujimoto WY, Barrett-Connor E, Haffner S, Hanson RL, et al. Relation of central adiposity and body mass index to the development of diabetes in the Diabetes Prevention Program. Am J Clin Nutr. 2008;87(5):1212\u20138.","journal-title":"Am J Clin Nutr."},{"issue":"3","key":"4436_CR16","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1093\/ije\/dyr029","volume":"40","author":"E Agardh","year":"2011","unstructured":"Agardh E, Allebeck P, Hallqvist J, Moradi T, Sidorchuk A. Type 2 diabetes incidence and socio-economic position: a systematic review and meta-analysis. Int J Epidemiol. 2011 Jun;40(3):804\u201318.","journal-title":"Int J Epidemiol."},{"issue":"9403","key":"4436_CR17","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","volume":"363","author":"World Health Organization","year":"2004","unstructured":"World Health Organization. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004 Jan 10;363(9403):157\u201363.","journal-title":"Lancet."},{"key":"#cr-split#-4436_CR18.1","unstructured":"4. U.S. Preventive Services Task Force. Guide to Clinical Preventive Services, 2014: Appendix A: How the U.S. Preventive Services Task Force Grades Its Recommendations. Agency for Healthcare Research and Quality, 2014"},{"key":"#cr-split#-4436_CR18.2","unstructured":"5. Available from:   https:\/\/www.ahrq.gov\/professionals\/clinicians-providers\/guidelines-recommendations\/guide\/appendix-a.html    [accessed February 27, 2018]."},{"key":"#cr-split#-4436_CR19.1","unstructured":"6. U.S. Preventive Services Task Force. Grade Definitions, 2016"},{"key":"#cr-split#-4436_CR19.2","unstructured":"7. Available from:   https:\/\/www.uspreventiveservicestaskforce.org\/Page\/Name\/grade-definitions    [accessed February 27, 2018]."},{"issue":"19","key":"4436_CR20","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1001\/jama.2015.13154","volume":"314","author":"AL Siu","year":"2015","unstructured":"Siu AL, Bibbins-Domingo K, Grossman D. Evidence-Based Clinical Prevention in the Era of the Patient Protection and Affordable Care Act: The Role of the US Preventive Services Task Force. JAMA. 2015 Nov 17;314(19):2021\u20132.","journal-title":"JAMA."},{"key":"#cr-split#-4436_CR21.1","unstructured":"8. Diabetes Advocacy Alliance. Coalition Letter: Request to release FAQ regarding coverage of preventive services under the Affordable Care Act (ACA). American Association of Clinical Endocrinologists, 2016"},{"key":"#cr-split#-4436_CR21.2","unstructured":"9. Available from:   https:\/\/www.aace.com\/files\/views\/072616-tridpts-re-diabetes-screening.pdf    [accessed February 27, 2018]."},{"key":"4436_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1478-7954-12-12","volume":"12","author":"TM Dall","year":"2014","unstructured":"Dall TM, Narayan KM, Gillespie KB, Gallo PD, Blanchard TD, Solcan M, et al. Detecting type 2 diabetes and prediabetes among asymptomatic adults in the United States: modeling American Diabetes Association versus US Preventive Services Task Force diabetes screening guidelines. Popul Health Metr. 2014;12:1\u201314.","journal-title":"Popul Health Metr."},{"issue":"4","key":"4436_CR23","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.amepre.2014.05.012","volume":"47","author":"S Chung","year":"2014","unstructured":"Chung S, Azar KM, Baek M, Lauderdale DS, Palaniappan LP. Reconsidering the age thresholds for type II diabetes screening in the U.S. Am J Prev Med. 2014 Oct;47(4):375\u201381.","journal-title":"Am J Prev Med."},{"issue":"2","key":"4436_CR24","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.amepre.2013.02.026","volume":"45","author":"SS Casagrande","year":"2013","unstructured":"Casagrande SS, Cowie CC, Fradkin JE. Utility of the U.S. Preventive Services Task Force criteria for diabetes screening. Am J Prev Med. 2013 Aug;45(2):167\u201374.","journal-title":"Am J Prev Med."},{"issue":"4","key":"4436_CR25","doi-asserted-by":"publisher","first-page":"e0125249","DOI":"10.1371\/journal.pone.0125249","volume":"10","author":"KM Bullard","year":"2015","unstructured":"Bullard KM, Ali MK, Imperatore G, Geiss LS, Saydah SH, Albu JB, et al. Receipt of Glucose Testing and Performance of Two US Diabetes Screening Guidelines, 2007-2012. PLoS One. 2015;10(4):e0125249.","journal-title":"PLoS One."},{"issue":"7","key":"4436_CR26","doi-asserted-by":"publisher","first-page":"e1002074","DOI":"10.1371\/journal.pmed.1002074","volume":"13","author":"MJ O'Brien","year":"2016","unstructured":"O'Brien MJ, Lee JY, Carnethon MR, Ackermann RT, Vargas MC, Hamilton A, et al. Detecting Dysglycemia Using the 2015 United States Preventive Services Task Force Screening Criteria: A Cohort Analysis of Community Health Center Patients. PLoS Med. 2016 Jul;13(7):e1002074.","journal-title":"PLoS Med."},{"issue":"1","key":"4436_CR27","doi-asserted-by":"publisher","first-page":"150","DOI":"10.2337\/dc14-2391","volume":"38","author":"WC Hsu","year":"2015","unstructured":"Hsu WC, Araneta MR, Kanaya AM, Chiang JL, Fujimoto W. BMI cut points to identify at-risk Asian Americans for type 2 diabetes screening. Diabetes Care. 2015;38(1):150\u20138.","journal-title":"Diabetes Care."},{"issue":"10","key":"4436_CR28","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1001\/jama.2016.0299","volume":"315","author":"KJ Lipska","year":"2016","unstructured":"Lipska KJ, Krumholz H, Soones T, Lee SJ. Polypharmacy in the Aging Patient: A Review of Glycemic Control in Older Adults With Type 2 Diabetes. JAMA. 2016;315(10):1034\u201345.","journal-title":"JAMA."},{"key":"#cr-split#-4436_CR29.1","unstructured":"10. Community Preventive Services Task Force. Diabetes Prevention and Control: Combined Diet & Physical Activity Programs- Economic Evidence Tables. Atlanta, GA 2016"},{"key":"#cr-split#-4436_CR29.2","unstructured":"11. Available from:   https:\/\/www.thecommunityguide.org\/sites\/default\/files\/assets\/SETcombineddietandpa-econ.pdf    [accessed February 27, 2018]."},{"issue":"1","key":"4436_CR30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2337\/diacare.27.1.9","volume":"27","author":"MW Ealovega","year":"2004","unstructured":"Ealovega MW, Tabaei BP, Brandle M, Burke R, Herman WH. Opportunistic screening for diabetes in routine clinical practice. Diabetes Care. 2004 Jan;27(1):9\u201312.","journal-title":"Diabetes Care."},{"issue":"25","key":"4436_CR31","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1056\/NEJMoa052187","volume":"353","author":"DM Nathan","year":"2005","unstructured":"Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005 Dec 22;353(25):2643\u201353.","journal-title":"N Engl J Med."},{"issue":"19","key":"4436_CR32","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1001\/jama.287.19.2563","volume":"287","author":"DCCT-EDIC Writing Group","year":"2002","unstructured":"DCCT-EDIC Writing Group. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA. 2002 May 15;287(19):2563\u20139.","journal-title":"JAMA."},{"issue":"2","key":"4436_CR33","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1001\/jama.285.2.182","volume":"285","author":"EH Wagner","year":"2001","unstructured":"Wagner EH, Sandhu N, Newton KM, McCulloch DK, Ramsey SD, Grothaus LC. Effect of improved glycemic control on health care costs and utilization. JAMA. 2001;285(2):182\u20139.","journal-title":"JAMA."},{"key":"4436_CR34","doi-asserted-by":"publisher","first-page":"h454","DOI":"10.1136\/bmj.h454","volume":"350","author":"JB Sussman","year":"2015","unstructured":"Sussman JB, Kent DM, Nelson JP, Hayward RA. Improving diabetes prevention with benefit based tailored treatment: risk based reanalysis of Diabetes Prevention Program. BMJ. 2015;350:h454.","journal-title":"BMJ."},{"issue":"12","key":"4436_CR35","doi-asserted-by":"publisher","first-page":"3992","DOI":"10.2337\/dc13-0497","volume":"36","author":"X Zhuo","year":"2013","unstructured":"Zhuo X, Zhang P, Kahn HS, Gregg EW. Cost-Effectiveness of Alternative Thresholds of the Fasting Plasma Glucose Test to Identify the Target Population for Type 2 Diabetes Prevention in Adults Aged\u2265 45 Years. Diabetes Care. 2013;36(12):3992\u20138.","journal-title":"Diabetes Care."},{"issue":"9626","key":"4436_CR36","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1016\/S0140-6736(08)60766-7","volume":"371","author":"G Li","year":"2008","unstructured":"Li G, Zhang P, Wang J, Gregg EW, Yang W, Gong Q, et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet. 2008;371(9626):1783\u20139.","journal-title":"Lancet."},{"issue":"9702","key":"4436_CR37","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/S0140-6736(09)61457-4","volume":"374","author":"W Knowler","year":"2009","unstructured":"Knowler W, Fowler S, Hamman R, Christophi C, Hoffman H, Brenneman A, et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009;374(9702):1677.","journal-title":"Lancet."},{"issue":"2","key":"4436_CR38","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s00125-010-1948-9","volume":"54","author":"Q Gong","year":"2011","unstructured":"Gong Q, Gregg EW, Wang J, An Y, Zhang P, Yang W, et al. Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study. Diabetologia. 2011 Feb;54(2):300\u20137.","journal-title":"Diabetologia."},{"issue":"11","key":"4436_CR39","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/S2213-8587(15)00291-0","volume":"3","author":"Diabetes Prevention Program Research Group","year":"2015","unstructured":"Diabetes Prevention Program Research Group. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study. Lancet Diabetes Endocrinol. 2015 Nov;3(11):866\u201375.","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"6","key":"4436_CR40","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/S2213-8587(14)70057-9","volume":"2","author":"G Li","year":"2014","unstructured":"Li G, Zhang P, Wang J, An Y, Gong Q, Gregg EW, et al. Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study. Lancet Diabetes Endocrinol. 2014;2(6):474\u201380.","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"3","key":"4436_CR41","doi-asserted-by":"publisher","first-page":"574","DOI":"10.2337\/dc12-0722","volume":"36","author":"AJ Karter","year":"2013","unstructured":"Karter AJ, Schillinger D, Adams AS, Moffet HH, Liu J, Adler NE, et al. Elevated rates of diabetes in Pacific Islanders and Asian subgroups: The Diabetes Study of Northern California (DISTANCE). Diabetes Care. 2013 Mar;36(3):574\u20139.","journal-title":"Diabetes Care."},{"issue":"11","key":"4436_CR42","doi-asserted-by":"publisher","first-page":"769","DOI":"10.7326\/M17-1272","volume":"167","author":"E Selvin","year":"2017","unstructured":"Selvin E, Wang D, Lee AK, Bergenstal RM, Coresh J. Identifying Trends in Undiagnosed Diabetes in U.S. Adults by Using a Confirmatory Definition: A Cross-sectional Study. Ann Intern Med. 2017;167(11):769\u201376.","journal-title":"Ann Intern Med."},{"issue":"2","key":"4436_CR43","doi-asserted-by":"publisher","first-page":"518","DOI":"10.2337\/dc10-1546","volume":"34","author":"DB Sacks","year":"2011","unstructured":"Sacks DB. A1C versus glucose testing: a comparison. Diabetes Care. 2011;34(2):518\u201323.","journal-title":"Diabetes Care."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11606-018-4436-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-018-4436-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-018-4436-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,11]],"date-time":"2019-04-11T20:03:12Z","timestamp":1555012992000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11606-018-4436-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,12]]},"references-count":48,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["4436"],"URL":"https:\/\/doi.org\/10.1007\/s11606-018-4436-4","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,12]]},"assertion":[{"value":"21 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The National Center for Health Statistics Research Ethics Review Board approved NHANES. All participants gave informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they do not have a conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}